Author:
Borghi C,Acelajado M C,Gupta Y,Jain S
Publisher
Springer Science and Business Media LLC
Reference36 articles.
1. World Health Organization. (2013). A global brief on Hypertension: Silent killer, global public health crisis. WHO: Geneva, Switzerland, 2013 http://ish-world.com/downloads/pdf/global_brief_hypertension.pdf (accessed on 18 Feb 2016).
2. McEniery CM, Cockcroft JR, Roman MJ, Franklin SS, Wilkinson IB . Central blood pressure: current evidence and clinical importance. Eur Heart J 2014; 35: 1719–1725.
3. Protogerou AD, Papaioannou TG, Blacher J, Papamichael CM, Lekakis JP, Safar ME . Central blood pressures: do we need them in the management of cardiovascular disease? Is it a feasible therapeutic target? J Hypertens 2007; 25: 265–272.
4. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation 2006; 113: 1213–1225.
5. Agabiti-Rosei E, Porteri E, Rizzoni D . Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag 2009; 5: 353–360.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献